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Abstract
Background: Keeping current with drug therapy information is challenging for health care practitioners. Technologies are often
implemented to facilitate access to current and credible drug information sources. In the Canadian province of Nova Scotia,
legislation was passed in 2002 to allow nurse practitioners (NPs) to practice collaboratively with physician partners. The purpose
of this study was to determine the current utilization patterns of information technologies by these groups of practitioners.
Methods: Nurse practitioners and their collaborating physician partners in Nova Scotia were sent a survey in February 2005
to determine the frequency of use, usefulness, accessibility, credibility, and current/timeliness of personal digital assistant (PDA),
computer, and print drug information resources. Two surveys were developed (one for PDA users and one for computer users)
and revised based on a literature search, stakeholder consultation, and pilot-testing results. A second distribution to
nonresponders occurred two weeks following the first. Data were entered and analysed with SPSS.
Results: Twenty-seven (14 NPs and 13 physicians) of 36 (75%) recipients responded. 22% (6) returned personal digital assistant
(PDA) surveys. Respondents reported print, health professionals, and online/electronic resources as the most to least preferred
means to access drug information, respectively. 37% and 35% of respondents reported using "both print and electronic but print
more than electronic" and "print only", respectively, to search monograph-related drug information queries whereas 4%
reported using "PDA only". Analysis of respondent ratings for all resources in the categories print,  health professionals and
other, and online/electronic resources, indicated  that the Compendium of Pharmaceuticals and Specialties and pharmacists
ranked highly for frequency of use, usefulness, accessibility, credibility,  and current/timeliness by both groups of practitioners.
Respondents' preferences and resource ratings were consistent with self-reported methods for conducting drug information
queries. Few differences existed between NP and physician rankings of resources.
Conclusion: The use of computers and PDAs remains limited, which is also consistent with preferred and frequent use of print
resources. Education for these practitioners regarding available electronic drug information resources may facilitate future
computer and PDA use. Further research is needed to determine methods to increase computer and PDA use and whether
these technologies affect prescribing and patient outcomes.
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Background
Challenges with knowledge management for health care 
professionals
In 1986, Haynes et al. published a series of 6 articles enti-
tled "how to keep up with the medical literature" in an
effort to help clinicians with information management,
but this challenge has not decreased in last two decades
[1-6]. Alper et al. suggest that maintaining currency with
relevant literature in primary care would "require 627.5
hours per month, or about 29 hours per weekday, or 3.6
full-time equivalents of physician effort" [7]. The volume
of information associated with keeping up to date is fre-
quently cited as a barrier [8]. It is estimated that annually
there are approximately 10,000 new randomized trials in
MEDLINE and over 450,000 clinical trials identified by
the Cochrane Collaboration [9,10]. Keeping up to date
has been described with several analogies including clini-
cians attempting to drink water from a fire hose and
swimming in rivers of clinical research with unprece-
dented depth, velocity, and turbulence [11,12].
Difficulties with dissemination of research evidence and
keeping up to date on pharmacotherapeutic interventions
are reported despite the development of tools such as clin-
ical practice guidelines and systematic reviews that are
intended to reduce the need for practitioners to evaluate
original research [13]. To complicate matters further,
there are often issues of credibility, timeliness, and vol-
ume of clinical practice guidelines and reviews. Many
guidelines are criticized for their methodological develop-
ment. Shaneyfelt et al. reviewed 279 guidelines for meth-
odological standards from peer reviewed medical
literature [14]. These authors found that only 51%,
33.6%, and 46% adhered to standards on guideline devel-
opment and format, evidence identification and sum-
mary, and formulation of recommendations, respectively
[14]. A Canadian review on drug therapy guidelines found
significant variation in quality depending on the devel-
oper [13]. Approximately 25% of guidelines were not rec-
ommended for use in practice by the appraisers' criteria
[13]. As an example of the volume of clinical practice
guidelines available, eleven recent guidelines on commu-
nity acquired pneumonia exist [15]. To add to the com-
plexities involved with keeping current with
pharmacotherapeutic management strategies, as of 2000,
there were over 22,000 drug products approved for sale in
Canada for human use [16].
There is also considerable debate regarding what consti-
tutes "evidence" in practice, which contributes to confu-
sion for clinicians [17,18]. Sim et al. succinctly describe
the gap between evidence and action as difficulties with
obtaining, systematically reviewing, applying in context,
and measuring the outcome following application of evi-
dence [19].
Maintaining competence – nurse practitioners as a new 
group of prescribers
Competencies for nurse practitioners (NPs) on a local and
international level include critically appraising and apply-
ing literature and research findings in practice [20-23].
The Canadian Nurses Association (CNA) has developed
the Canadian Nurse Practitioner Core Competency
Framework that describes the knowledge, skills, judg-
ment, and attributes required for practice. Evidence based
practice is integral to pharmacotherapeutic interventions
and prescribing competencies [23]. The National Prescrib-
ing Centre, an organization of the National Health Service
in the UK, describes several competencies around infor-
mation needs relevant to prescribing and emphasis is
placed on using relevant and up to date information in
various formats (e.g. print, electronic, verbal). Several
related competencies include understanding advantages
and disadvantages of information sources and the cur-
rency of resources [21]. Researchers in the US developed
NP informatics competencies for integration into
advanced nursing practice curricula [24]. Competencies
related to informatics knowledge include critical analysis
of data and information for use in evidence based prac-
tice, evaluating and applying relevant information, syn-
thesizing best evidence, and using optimal search
strategies to locate clinically sound and useful studies
from information resources [24]. Achieving and main-
taining competence in these domains as well as a solid
foundation in pharmacology is necessary to support NPs
in their relatively new role as a prescriber [25-27].
Knowledge management and information seeking 
behaviours among nurse practitioners and physicians
Information seeking behaviours of physicians are better
documented than NPs [11]. Information related to diag-
nosis is important to both groups but drug therapy que-
ries may occur more frequently with NPs [28-33].
Research on nurses' behaviours related to information
seeking is available from the hospital setting [33-35] but
the generalizability of these behaviours to NPs with a pre-
scribing role is unclear. Differences in nursing roles,
responsibilities, and legislation, including prescriptive
authority, exist depending on the country of practice.
Nurse practitioners and their collaborating physician 
partners in Nova Scotia
Nova Scotia is a Canadian province with a population of
approximately 942,000 [36]. The province is divided into
six health zones that include nine district health authori-
ties, one of which includes the provincial capital and is
considered to be urban [37,38]. Health care service deliv-
ery is challenging due to many factors including the rural
nature of the province, which is estimated to be 60% of
population [37,39].BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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Starting in 1998, the Nova Scotia Department of Health
led an initiative to explore different methods of deliver-
ing, managing, and funding primary care services. The
Strengthening Primary Care in Nova Scotia Communities
Initiative (SPCI) was established with the selection of four
primary care demonstration sites where a primary health
care NP was hired to practice collaboratively with one or
more family/general physicians and other members of an
interdisciplinary team. Each demonstration site adopted
alternative (non fee-for-service) physician payment mech-
anisms and used electronic patient records (EPRs) to sup-
port service delivery [41]. Demonstration sites
participated in project evaluation components that
included, but were not limited to, NP roles, alternative fee
structures, consumer satisfaction, and implementation
and integration of EPRs [41,42].
Legislation to allow NPs to practice collaboratively with
physicians in Nova Scotia was passed in 2002, part way
through the SPCI project [39]. Prescriptive authority
granted through legislation authorizes NPs to prescribe
from a schedule of drugs [43,44]. At the time of conduct-
ing this research project, 16 primary health care NPs were
in active practice [43].
The EPR component of the SPCI project evaluation pro-
vided information on the use of technologies in the com-
munity context. Results from the implementation process
indicated that considerable attention is required for tech-
nology literacy, time for training, and selection of soft-
ware for EPRs [41]. Although the majority of community-
based, non-institutional clinical practice settings in Nova
Scotia primarily operate with paper-based charting sys-
tems, there is a movement toward integrating electronic
technologies, including the EPR, in practice among health
care providers, administrators, and the provincial govern-
ment. In addition to recording patient visit information, a
component of the EPR package serves to provide drug
information resources.
Drug therapy information resources for NPs and nurse
prescribers have frequently been described as essential in
supporting practice [25,28,29]. The role of NPs is rela-
tively new in Canada [39] and there is limited informa-
tion available to indicate the type of resources (e.g. print,
electronic, EPR based) these prescribers use for drug and
therapeutic information queries at the point of care. It is
unknown as to whether differences exist regarding types
of resources used, drug information needs, and utilization
patterns among NPs and collaborating physician partners.
Some research has suggested that the degree of multidisci-
plinary team functioning relates to the adoption of tech-
nology or innovations in practice but more research is
required to determine the extent of these relationships
[45,46].
The use of EPR technology is increasing in Nova Scotia but
little information is available regarding the readiness of
practitioners for use of specific features such as drug infor-
mation resources. Based on the EPR related results of the
SPCI evaluation, use of these functions could be challeng-
ing without proper facilitation. The purpose of the survey
for this research was to describe drug information
resources used by NPs and their collaborating physician
partners at the point of care. The results of the survey will
be used to guide further technology implementation strat-
egies and stimulate further discussion around drug infor-
mation resource usage at the point of care.
Methods
Survey development
Survey development involved three stages including iden-
tification of important content areas, development of
draft questions, and survey refinement.
Identifying important content areas for inclusion in the
survey involved conducting a comprehensive English lan-
guage literature search, consultation with relevant stake-
holders (e.g. members of the Nova Scotia Department of
Health), and input from subject matter experts at Dalhou-
sie University. The literature review was conducted using
the following bibliographic databases: PubMed, Cumula-
tive Index to Nursing and Allied Health Literature
(CINAHL), International Pharmaceutical Abstracts (IPA),
and Web of Science Citation Databases. Hand and elec-
tronic searching of relevant journals was also conducted.
Broad search terms were used without limits on publica-
tion date or place as nurse practitioner titles, roles and
scopes of practice, and terminology regarding technology
vary nationally and internationally. Some examples of
terms used included nurse practitioner, nurse prescriber,
nurse clinicians, district nurse, health visitor, drug infor-
mation resources, drug information services, information
needs, and information technology.
The draft survey was reviewed by the research team to
reduce the number of items and improve clarity. The lay-
out of the questionnaire was carefully examined to ensure
that it was easy to follow and complete. Research results
from a previous investigation of Nova Scotian physicians'
behaviours regarding drug information were also used to
further revise the survey [47]. This draft questionnaire was
pilot tested by two out of province NPs and one physician.
The results of the pilot were used to make final revisions
to the survey. Based on pilot-testing feedback and investi-
gator consensus, the final survey was divided into 2 ver-
sions, one for personal digital assistant (PDA) users and
one for computer users.
The 10 page surveys for PDA and computer users had 5 or
6 sections, respectively, and 37 questions, many with mul-BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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tiple parts. The survey content included demographics,
computer or PDA use and experience, drug and therapeu-
tic resource use and preferences, PDA future use, perceived
barriers and facilitators to PDA use, and technology train-
ing preferences.
Section one contained demographic questions such as
gender, age, job title, volume of patients, and EPR availa-
bility in the practice setting. Section two was designed to
determine PDA or computer use and experience in the
practice setting with questions regarding length of use,
costs, and work versus home usage. This section also
addressed usage and rating of different drug information
resources. Resource ratings were based on the frequency of
usage, usefulness, accessibility, credibility, and current/
timeliness. Resources were grouped as print (i.e. books,
journals, and clinical practice guidelines), online/elec-
tronic resources, and health professionals and other.
Respondents used 5-point Likert scales (strongly agree to
strongly disagree) for rating opinions related to resources.
A rating of 6 (not applicable, I do not use this resource)
was also included for respondents who did not use a par-
ticular resource. Frequency of searching for specific infor-
mation was rated on a 3-point Likert scale (frequently to
never). The final sections of the survey included categori-
cal, open-ended, and Likert scale questions regarding pre-
ferred resources, technology barriers, PDA future use, and
technology training preferences. Copies of the surveys are
attached as an appendix in PDF format [see additional file
1 and 2] or can also be accessed from the Initiative for
Medication Management, Policy Analysis, Research &
Training (IMPART) website [48].
Ethics approval for the survey was granted through Dal-
housie University Research Ethics Board on February 3,
2005.
Survey population
Licensed, actively practicing, primary health care NPs (n =
16) and their collaborating physician partners (n = 21)
were eligible to participate.
Survey procedures
The survey recruitment procedures were based on the
methods of Dillman [49] and Salant and Dillman [50].
Survey packages contained a cover letter, separate surveys
for PDA and computer users, and a return self-addressed
stamped envelope. The covering letter instructed respond-
ents to self-select the appropriate survey (either PDA or
computer) based on their drug information seeking
behaviours. Participants who had used a PDA at any time
were instructed to complete the PDA version of the survey.
Those who had never used a PDA for drug information
were instructed to complete the computer version of the
survey. Several strategies were used to optimize response
rate and included: personalized cover letters, coloured
paper for surveys, stamped return envelopes, follow-up
mailing, and a priority post mailing [51]. The covering let-
ter included coloured logos of Dalhousie University and
the Nova Scotia Department of Health representing the
investigator affiliations and endorsement of the project.
A master mailing list with names and addresses of NPs
and their collaborating physician partners was created. To
maintain confidentiality of respondents, a number placed
on the bottom right corner of each survey corresponded to
a name on the confidential master mailing sheet. The
postage paid return envelopes were addressed to the
research coordinator at the School of Nursing, Dalhousie
University, who matched respondents to the mailing list
from the first distribution. The cross-referenced mailing
list was not accessible to those entering or analysing data.
The research coordinator sent the second distribution to
those who had not initially responded. A fluorescent col-
oured page was included in the second mailing to notify
recipients of the second and final mailing status. The sec-
ond mailing followed 2 weeks after the initial mailing
(February 2005). The surveys were sent via Xpresspost™
through Canada Post.
Data analyses
Quantitative
Data were entered and analysed in Statistical Package for
Social Sciences (SPSS) (version 11.5 for Windows). Five
surveys were randomly selected as a check for accuracy of
data entry. Descriptive statistics were used to describe
resource usage by practitioners. Chi Square (Fisher's Exact
when cell count less than 5) analyses were used to deter-
mine differences in computer or PDA use based on prede-
termined variables (e.g. high speed Internet connection,
number of patients per day). Mann Whitney U tests were
used to compare physician and NPs Likert scale ratings (1
= strongly agree to 5 = strongly disagree) of resource use.
Physician and NP rankings of all resources (print, online/
electronic, and health professionals and other) were deter-
mined from means of Likert scale ratings (1 = strongly
agree, 5 = strongly disagree) for each of the pre-specified
characteristics (e.g. frequency of use, accessibility, etc.)
and the frequency of use of the resources. The best rank-
ings were assigned for the lowest mean scores and the larg-
est number of the sample using a resource. These rankings
(ranks based on mean and ranks based on sample) were
then entered into a formula to calculate an overall rank.
The formula includes: rank = [(rank according to % of
sample using the resource + rank based on mean score) ÷
2]. This formula was used to account for mean scores
based on small samples as these numbers could poten-
tially over or underestimate the value of a resource. Rat-
ings of 6 (i.e. not applicable, I do not use this resource)
were excluded from the analyses.BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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Qualitative
Comments were entered in a word-processing program
and organized by type of respondent (PDA versus compu-
ter) and question number. The coded survey number and
respondent type (NP or physician) were also included
next to comments. Investigators determined themes and
categorized comments based on previous experience,
knowledge, and familiarity with the topic.
Results
Surveys were completed and returned by 75% of eligible
participants (27 of 36). One physician survey was unde-
liverable. The response rates from within the NP and phy-
sician samples were 88% and 65%, respectively.
Complete demographic information is available in Table
1.
Methods for accessing resources and self-reported 
resource use
Resource use was similar amongst practitioners. Respond-
ents indicated that print resources (mean 4.56, SD 0.80),
health professionals (mean 3.26, SD 0.90), and online/
electronic resources (mean 2.70, SD 1.20) were the pre-
ferred method (1 = least preferred to 5 = most preferred)
for accessing drug information. Thirty-seven percent of
respondents reported that searching for specific questions
related to drug information (e.g. usual dosage, duration of
therapy) was conducted using both print and electronic
resources (but print use greater than electronic) (Table 2).
The preferred means (i.e. print) to access resources was
consistent with the most common means of conducting
searches for specific drug information queries.
Respondents' ratings for pre-specified print, online/elec-
tronic, and professional resources and other, based on
means from Likert scales and number of respondents
using the resources, are presented in Tables 3, 4, and 5. Of
all resources within the print, online/electronic, and
health professionals or other categories, NPs and physi-
cians rated the Compendium of Pharmaceuticals and Spe-
cialties (CPS) [52] and pharmacists as the top two most
frequently used resources for providing drug and thera-
peutic information. Physicians rated other physicians as
the third most frequently used resource. The book Thera-
peutic Choices [53] ranked third for NPs. Based on written
feedback, physicians and NPs consulted pharmacists and
other physicians most frequently. The CPS and pharma-
cists were also ranked as the top two resources overall in
terms of usefulness, accessibility, credibility, and current/
timeliness for physicians. Rankings by NPs were similar
for usefulness, accessibility, and credibility. NPs ranked
pharmacists, Therapeutic Choices, and academic detailing
first and the CPS as second for current/timeliness.
Within the online/electronic category, electronic clinical
practice guidelines (eCPGs) were rated the highest for all
characteristics (e.g. usefulness, credibility). Although
eCPGs were highly ranked, approximately 30% of the
sample reported not using this resource. Other resources
in this category were infrequently used based on respond-
ents' self-reports.
Pharmaceutical industry representatives were used as a
source of drug information by 85% and 86% of physi-
cians and NPs, respectively (Table 5). This was higher than
regional drug information services (used by 23% of phy-
sicians and 50% of NPs). After exclusion of traditional
health professionals (i.e. physicians, nurses, pharmacists,
allied health) in the health professionals and other cate-
gory, pharmaceutical industry representatives received
rankings for second or third for frequency of use, useful-
ness, accessibility, credibility, and current/timeliness,
based on means and number of respondents using this
resource (data not shown).
Differences between nurse practitioners and physicians
A series of Mann Whitney U tests were used to compare
the responses of NPs and physicians on their use of print,
online/electronic, and health professional resources. In
Table 1: Demographics of nurse practitioner and collaborating 
physician partner respondents.
Characteristic Descriptor N (%)
Practitioner type Nurse practitioner 14* 52
Physician 13 48
Gender Male 9 33
Female 18 67
Age ≤ 25 2 7
26 – 35 4 15
36 – 55 16 59
56 – 65 4 15
≥ 66 1 4
Survey type Personal digital assistant† 62 2
Computer 21 78
Patient volume Mean patients/day/week‡
<15 11 41
16–25 11 41
26–35 2 7
36–45 2 7
>46 1 4
Technologies available High speed internet at work§
Yes 15 56
No 10 37
Electronic Patient Record
Yes 10 37
No 17 63
* represents 88% (14/16) response rate within the nurse practitioner 
population.
† 1 and 5 personal digital assistant surveys received from nurse 
practitioners and general practitioners, respectively.
‡ mean number of patients seen by the practitioner per day in a week.
§totals do not add up to 100% due to 2 non-responses.BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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total 95 statistical tests were conducted. The large number
of tests increases the likelihood of a type I error as five sig-
nificant differences would be expected by chance alone at
an alpha threshold of 0.05. It is therefore important to
treat these results with caution. A limited number of sta-
tistically significant (p < 0.05) differences were identified
between physicians and NPs and are reported in Table 6.
Therapeutic Choices differed significantly for frequency of
use with more NPs making use of this resource. Allied
health professionals significantly differed between NPs
and physicians for accessibility and current/timeliness
while NPs were more in agreement with these characteris-
tics of the resource. Nurse colleague credibility and cur-
rent/timeliness was rated significantly higher by NPs
versus physicians.
Factors influencing electronic technology use at the point 
of care
Factors such as gender, age, practitioner type (NP vs phy-
sician), accessibility, technical support, Internet connec-
tion speed, patient volume, presence of an EPR, and home
computer use were examined to determine if they were
associated with the use of a work computer to search for
drug information at the point of care. No statistically sig-
nificant associations were found (Fisher's Exact).
Additional resources from respondent comments
Respondents indicated other resources and programs,
such as clinical calculators, that they would like to access
from their computer or PDA. The top three resources that
were desired included Canadian clinical practice guide-
lines, patient education information, and ability to track
clinical activities/statistics. Further comments from two
NP computer survey respondents revealed that a resource
on drug interactions and dosages would be desired. One
other NP also indicated "up to date info [sic] on drugs to
treat various illnesses ie doseage [sic], length of use etc."
Computer or personal digital assistant use in practice
Approximately 50% of computer survey respondents
reported using their work computers for searching drug or
therapeutic information related to patient care. Of those
respondents, just over half (54%) also reported using
their home computer for this purpose. Sixty-seven and
17% of PDA survey respondents reported using their PDA
for searching drug or therapeutic information related to
patient care at work and home, respectively.
Searching on a weekly basis for specific information 
related to drugs
Of the 24 specified categories of drug information
included in the survey, the majority were reported as infre-
quently searched and a smaller percentage as never
searched by respondents (data not shown). The top three
categories rated as frequently searched were side effects,
adult or usual drug dosage, and most appropriate drug for
an indication. (Table 7)
Issues related to personal digital assistants
Respondents reported their level of agreement with state-
ments related to how PDAs may influence their practice.
The statements included aspects of workload (organiza-
tion and paper work), convenience, and improving qual-
ity of care and patient outcomes. (Table 8) Respondents
agreed that PDAs are a convenient resource but indicated
that PDAs would not decrease paperwork or improve
patient health outcomes.
Barriers and facilitators to personal digital assistants: 
themes from written comments
Peer support from colleagues, convenience, standardized
usage, and financial and technical support were the main
perceived facilitators to PDA use reported by respondents.
The main perceived barrier to PDA use reported by
respondents (n = 10) included cost. Other factors such as
technology literacy, time, lack of peer support, no high
speed internet for downloads, lack of needed resources,
keeping up to date on resources, and searching speed were
also reported.
Future use of personal digital assistants
Fifty-two percent, including current PDA users, reported
that they would use a PDA in the future. Twenty two per-
cent were  uncertain and 19% reported that they would
not use a PDA in the future. Two people did not respond.
Table 2: Most common means to search for specific drug information queries by nurse practitioners and collaborating physicians
Method to conduct searching % respondents
Print use is greater than electronic, although both used 37
Print only 35
Electronic use is greater than print, although both used 8
Print used more than electronic and/or personal digital assistant 4
Print and electronic used equally 4
Print, electronic, and personal digital assistant used equally 4
Personal digital assistant used more than electronic and/or print 4
Personal digital assistant only 4B
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Table 3: Print resource ratings (1 = strongly agree, 5 = strongly disagree) by physicians and nurse practitioners
Print
CPS TC Specialty books Print journals Print CPGs
Physician
(N = 13)
NP
(N = 14)
Physician
(N = 8)
NP
(N = 13)
Physician
(N = 10)
NP
(N = 12)
Physician
(N = 10)
NP
(N = 12)
Physician
(N = 12)
NP
(N = 14)
Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank*
Used frequently 1.62 
(0.96)
11 . 2 9  
(0.61)
12 . 7 5  
(1.39)
8.5 1.54 
(0.78)
2.5 2.30 
(0.67)
41 . 8 3  
(0.83)
3.5 2.70 
(1.25)
72 . 2 5  
(0.87)
52 . 5 8  
(1.00)
5.5 2.14 
(0.86)
3.5
Useful 1.46 
(0.52)
11 . 5 0  
(0.65)
1.5 2.00 
(1.00)
61 . 6 9  
(1.11)
2.5 1.88 
(0.83)
41 . 7 5  
(0.87)
3.5 2.40 
(0.97)
7.5 1.92 
(0.67)
5.5 2.25 
(0.87)
5.5 2.00 
(0.68)
5
Accessible 1.31 
(0.48)
11 . 3 6  
(0.63)
12 . 1 4  
(1.21)
51 . 3 8  
(0.51)
22 . 1 3  
(0.83)
3.5 1.75 
(0.75)
3.5 2.70 
(1.06)
82 . 3 3  
(0.99)
5.5 2.83 
(0.94)
7.5 2.36 
(0.84)
5
Credible 1.38 
(0.65)
11 . 3 6  
(0.50)
11 . 7 1  
(0.95)
4.5 1.38 
(0.65)
22 . 0 0  
(0.87)
5.5 1.67 
(0.78)
3.5 2.30 
(1.06)
7.5 1.83 
(0.83)
4.5 2.17 
(0.72)
5.5 2.00 
(0.88)
4.5
Current/timely 1.85 
(0.69)
2.5 1.86 
(0.77)
32 . 1 4  
(1.21)
6.5 1.54 
(0.66)
22 . 2 5  
(1.03)
6.5 1.83 
(0.83)
3.5 2.10 
(0.88)
51 . 9 2  
(0.79)
4.5 2.58 
(0.90)
6.5 2.21 
(0.89)
6.5
Abbreviations: NP: Nurse practitioner; CPS: Compendium of Pharmaceuticals and Specialities; TC: Therapeutic Choices
CPGs: Clinical practice guidelines
* Rank: calculated based on the formula: [(rank according to % of sample using the resource + rank based on mean score) ÷ 2]. Ranks based on the % of the sample using the reference and individual ranks 
for mean scores were assigned within the groups used frequently, usefulness, accessibility, credibility, and current/timeliness for all resources regardless of their category (i.e. print, online/electronic, health 
professionals or other).B
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Table 4: Online/electronic resource ratings (1 = strongly agree, 5 = strongly disagree) by physicians and nurse practitioners
Online/electronic
Online journals Online bibliographies Electronic CPGs Cochrane Specialty websites
Physician
(N = 5)
NP
(N = 9)
Physician
(N = 4)
NP
(N = 7)
Physician
(N = 7)
NP
(N = 11)
Physician
(N = 6)
NP
(N = 7)
Physician
(N = 2)
NP
(N = 7)
Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank*
Used frequently 2.40 
(1.34)
7.5 2.44 
(1.42)
73 . 0 0  
(0.82)
11 2.86 
(1.07)
9.5 2.29 
(1.11)
52 . 4 5  
(1.04)
7 3.00 
(1.09)
10 3.43 
(1.13)
11 3.00 
(0.00)
12 1.86 
(0.69)
5.5
Useful 2.20 
(1.30)
8.5 2.29 
(1.50)
82 . 4 0  
(0.55)
10.5 2.43 
(1.13)
9.5 2.14 
(0.90)
72 . 1 8  
(0.87)
7 2.33 
(0.82)
9 2.00 
(0.82)
7.5 3.00 
(0.00)
13 1.86 
(0.69)
6.5
Accessible 2.60 
(1.14)
9.5 2.38 
(1.60)
7.5 2.40 
(0.55)
82 . 8 6  
(0.69)
9.5 2.14 
(0.90)
5.5 2.36 
(0.92)
6.5 2.50 
(1.05)
8 2.43 
(0.53)
8.5 3.00 
(0.00)
13.5 1.86 
(0.69)
5.5
Credible 2.20 
(1.30)
9.5 2.29 
(1.50)
7.5 1.80 
(0.84)
72 . 4 3  
(0.98)
92 . 0 0  
(0.82)
72 . 0 9  
(0.94)
6.5 1.67 
(0.52)
5 1.86 
(0.90)
6.5 3.00 
(0.00)
13 1.86 
(0.69)
6.5
Current/timely 2.20 
(1.30)
8.5 2.14 
(1.57)
71 . 6 0  
(0.89)
5.5 2.43 
(0.98)
10 2.00 
(0.82)
62 . 1 8  
(1.08)
7 1.83 
(0.75)
5.5 2.00 
(0.89)
6.5 3.00 
(0.00)
12.5 2.00 
(0.82)
6.5
Abbreviations: NP: Nurse practitioner; CPGs: Clinical practice guidelines
* Rank: calculated based on the formula: [(rank according to % of sample using the resource + rank based on mean score) ÷ 2]. Ranks based on the % of the sample using the reference and individual ranks 
for mean scores were assigned within the groups used frequently, usefulness, accessibility, credibility, and current/timeliness for all resources regardless of their category (i.e. print, online/electronic, health 
professionals or other).B
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Table 5: Health professionals and other resource ratings (1 = strongly agree, 5 = strongly disagree) by physicians and nurse practitioners
Health professionals and other
Physicians Nurses Pharmacists Other health professionals 
(e.g. dietician)
Physician
(N = 13)
NP
(N = 14)
Physician
(N = 12)
NP
(N = 13)
Physician
(N = 13)
NP
(N = 14)
Physician
(N = 9)
NP
(N = 12)
Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank*
Used frequently 2.31 
(1.11)
31 . 8 6  
(0.95)
32 . 7 5  
(0.87)
6.5 2.62 
(0.96)
72 . 0 0  
(1.29)
1.5 1.43 
(0.65)
1.5 2.56 
(0.88)
6.5 2.25 
(0.62)
5
Useful 1.85 
(0.80)
21 . 5 0  
(0.65)
1.5 2.33 
(0.78)
61 . 8 5  
(0.55)
41 . 7 7  
(0.83)
1.5 1.43 
(0.65)
1 2.44 
(0.53)
8.5 1.83 
(0.72)
4
Accessible 2.46 
(0.88)
42 . 0 0  
(1.04)
3.5 2.50 
(0.80)
52 . 4 6  
(0.78)
71 . 6 9  
(0.63)
1.5 1.50 
(0.65)
2 2.67 
(0.50)
82 . 0 0  
(0.43)
4.5
Credible 2.08 
(0.76)
4.5 1.64 
(0.75)
22 . 5 8  
(0.67)
7.5 1.85 
(0.55)
4.5 1.85 
(0.90)
3.5 1.36 
(0.50)
1 2.44 
(0.53)
8.5 1.83 
(0.58)
4.5
Current/ timely 2.25 
(0.87)
52 . 0 0  
(0.68)
42 . 5 8  
(0.67)
6.5 2.08 
(0.49)
51 . 7 7  
(0.73)
1.5 1.64 
(0.63)
2 2.56 
(0.53)
7.5 1.92 
(0.51)
4.5
Online chat/discussion groups Academic detailing Regional DI service Pharmaceutical company DI Pharmaceutical 
representatives
Physician
(N = 2)
NP
(N = 5)
Physician
(N = 12)
NP
(N = 12)
Physician
 (N = 3)
NP
(N = 7)
Physician 
(N = 2)
NP
 (N = 6)
Physician
(N = 11)
NP
(N = 12)
Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank* Mean 
(SD)
Rank*
Used frequently 3.50 
(0.71)
13.5 2.60 
(1.14)
9.5 2.50 
(0.91)
4.5 2.42 
(1.00)
5.5 3.33 
(0.58)
12.5 3.29 
(0.76)
10.5 3.50 
(0.71)
13.5 3.67 
(1.03)
12 3.18 
(1.25)
83 . 1 7  
(1.11)
8.5
Useful 2.50 
(0.71)
12.5 2.40 
(0.89)
10 1.92 
(0.67)
3.5 1.85 
(1.14)
4.5 2.00 
(1.00)
8.5 2.86 
(0.90)
10.5 3.00 
(0.00)
13 3.50 
(1.05)
11.5 3.18 
(1.08)
92 . 5 8  
(0.79)
8.5
Accessible 3.00 
(0.00)
13.5 2.20 
(0.84)
7.5 2.58 
(1.00)
5.5 2.38 
(1.33)
6.5 2.33 
(0.58)
83 . 1 4  
(0.69)
10 3.00 
(0.00)
13.5 3.33 
(1.21)
11 2.91 
(1.37)
8.5 3.08 
(1.24)
8
Credible 3.00 
(0.00)
13 2.40 
(0.89)
9.5 1.83 
(0.72)
3.5 1.77 
(0.93)
42 . 0 0  
(1.00)
92 . 8 6  
(0.90)
9.5 3.00 
(0.00)
13 3.67 
(0.82)
11 3.27 
(1.01)
92 . 9 2  
(0.90)
8.5
Current and 
timely
3.00 
(0.00)
12.5 2.20 
(0.84)
9.5 2.00 
(0.95)
3.5 1.46 
(0.52)
22 . 0 0  
(1.00)
82 . 8 6  
(0.90)
10.5 3.00 
(0.00)
12.5 3.50 
(1.05)
11.5 2.91 
(1.22)
7.5 2.42 
(0.79)
8
Abbreviations: NP: Nurse practitioner; DI: Drug information. * Rank: calculated based on the formula: [(rank according to % of sample using the resource + rank based on mean score) ÷ 2]. Ranks based on 
the % of the sample using the reference and individual ranks for mean scores were assigned within the groups used frequently, usefulness, accessibility, credibility, and current/timeliness for all resources 
regardless of their category (i.e. print, online/electronic, health professionals or other).BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
Page 10 of 15
(page number not for citation purposes)
Confidentiality
Fifty two percent of respondents indicated that patient
confidentiality with PDAs was no more concerning com-
pared to use of other technologies. Forty-four percent did
not know if they had a policy on patient confidentiality
with regard to technologies.
Technology training and reimbursement
Respondents rated (1 = least preferred to 5 = most pre-
ferred) one on one instruction and group learning led by
an expert facilitator as the most preferred (mean 4.32, SD
0.99) means by which to receive instruction on a new
technology. Least preferred methods included online dis-
cussions/chatrooms (mean 1.52, SD 1.04), internet vid-
eos (live: mean 1.70, SD 1.10, or static: mean 1.87, SD
1.14), video cassettes (mean 2.30, SD 1.55), trial and error
learning (mean 2.32, SD 1.28), and written manuals
(mean 2.92, SD 1.44). Paid leave for attendance at tech-
nology training sessions was the preferred means (mean
1.77, SD 0.86; 1 = strongly agree to 5 = strongly disagree)
of remuneration for respondents. Respondents also indi-
cated that if financial remuneration was to occur, it
should correspond to the amount of time for training that
is required (versus a flat rate) (mean 1.96, SD 1.08). Con-
tinuing education credits were not viewed as an incentive
(mean 2.69, SD 1.44).
Discussion
Preferred resources
In our study, printed materials (e.g. compendia, journals,
textbook resources) and professionals (e.g. pharmacists)
were the most preferred and frequently used means to
access information. Physician reliance on text and com-
pendia relative to online/electronic resources has been fre-
Table 7: Mean frequency of specific drug information queries searched on a weekly basis (frequently = 1, infrequently = 2, never = 3).
Category Frequency mean SD
Side effects 1.56 0.75
Adult or usual drug dosage 1.67 0.68
Most appropriate drug for indication 1.78 0.85
Drug interactions 1.81 0.79
Geriatric drug dosage 1.85 0.72
Information on new drugs 1.89 0.80
Pediatric drug dosage 1.96 0.71
Dosage forms (e.g. liquid) 1.96 0.76
Length of therapy 1.96 0.81
Indications 2.00 0.78
Dosage adjustment in organ dysfunction (e.g. renal) 2.07 0.73
Drug use in pregnancy and/or lactation 2.11 0.75
Pharmacokinetics (e.g. half-life, metabolism, excretion) 2.11 0.80
Non-prescription/Over the counter drug information 2.15 0.60
Herbal therapy information 2.19 0.62
Mechanism of action 2.19 0.68
Identification of drugs 2.27 0.67
Cost of drugs 2.27 0.83
New indication(s) for older drugs 2.33 0.62
Monitoring (e.g. phenytoin levels, bloodwork frequency) 2.33 0.68
Toxicology/treatment of overdose or poisoning 2.37 0.63
Formulary status (e.g. Nova Scotia Formulary) 2.41 0.69
Criteria for formulary exceptions status 2.42 0.76
Non-medicinal content of drugs (e.g. dyes) 2.56 0.51
Table 6: Significant Mann Whitney U results (p < 0.05) of nurse practitioner versus physician ratings for resources.
Resources and characteristic
Test statistic and p value Therapeutic 
Choices is used 
frequently
Nurses are 
credible
Nurse are current/
timely
Allied health 
professionals are 
accessible
Allied health 
professionals are 
current/timely
Mean score Physicians 15.27 16.83 16.04 14.67 14.28
NP 12.82 9.46 10.19 8.25 8.54
Mann-Whitney U 24.50 32.00 41.50 21.00 24.50
p value p = 0.045 p = 0.011 p = 0.046 p = 0.018 p = 0.034
Abbreviations: NP: Nurse practitionerBMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
Page 11 of 15
(page number not for citation purposes)
quently reported [11]. In a study examining family
doctors' use of information sources to answer clinical
questions, human resources (e.g. doctor, pharmacist),
non-prescribing print information (e.g. textbooks and
journal articles), and prescribing texts were used 36%,
32%, and 25% of the time, respectively [54]. Books from
the workplace were reported by approximately 79% of UK
primary care nurses as a commonly used source of knowl-
edge and information used to support practice [55]. Fewer
than one-third (31%) reported using electronic resources
(e.g. Internet, electronic journals) for this purpose [55].
Results of a postal questionnaire to NPs demonstrated
that 61% and 51% of respondents reported using drug ref-
erence manuals and textbooks, respectively, a few times a
week or more [29]. These frequencies were second and
third only to consulting with their physician supervisor
(63%). Data from structured interviews of a sample of 22
community nurse prescribers reported by Hall et al.
revealed that the majority relied on print materials to
access information, namely the British National Formu-
lary [32]. A survey of a primary care practice-based
research network in the US that included physicians, phy-
sician assistants, and nurse practitioners, revealed that
interpersonal and rapidly accessed print resources were
preferred. Sixty-one and 58% of respondents reported
using drug reference sources such as the Physician's Desk
Reference (PDR) and medical textbooks, respectively, a
few times a day or daily [56].
The clinicians in our sample perceived the Canadian com-
pendium, the CPS, to be useful, accessible, credible, and
current/timely. The CPS, is described as "the Canadian
drug reference for health professionals" and is intended to
provide a central source of drug information on drug
products available in Canada [52]. It is available in print
(English and French) and became available online in June
2004. The CPS includes drug monographs for commonly
used products approved for use in Canada, but it does not
include all drugs available on the Canadian market [57].
The majority of these product monographs are based on
monographs submitted by pharmaceutical manufacturers
and approved by Health Canada. Some of the mono-
graphs are written by the Canadian Pharmacists Associa-
tion and are described as being evidence-based [52]. The
CPS also includes more than 100 pages of clinical tools
[52]. The CPS has been criticized for including pharma-
ceutical company advertising and requiring manufacturer
payment for inclusion of product monographs [58]. The
accuracy of particular components of CPS monographs
has also been investigated. A review of overdose manage-
ment in 119 monographs from the 2001 CPS revealed
considerable variability in the utility of information with
50% of the monographs containing misleading or danger-
ous advice [59]. Since 2004, the CPS has included an alert
box in the overdose section of monographs notifying
users to contact Poison Control Centres for overdose
management information. Some authors have criticized
references that are similar to the CPS as being inadequate
with regard to inclusion of evidence based information
[60].
The NPs in our sample also rated Therapeutic Choices
highly for all characteristics.  This finding is most likely
attributable to the fact that it is a recommended resource
for coursework  associated with the Dalhousie NP univer-
sity program curriculum.  Therapeutic Choices is a concise
therapeutics reference text published by the Canadian
Pharmacists Association. The text contains approximately
120 extensively referenced chapters with a disease man-
agement approach including easy to use algorithms and
tables. An editorial board is responsible for extensively
reviewing the content to ensure unbiased and objective
information is presented [53].
Health professionals
Reliance on other health professionals, especially phar-
macists and physicians, as a resource for information was
evident from our study and concurs with the findings of
others [28,32,55,61]. Nurse practitioners have reported
that collaborative relationships with pharmacists increase
NP role satisfaction [61]. NPs frequently consult with
allied health care professionals in their primary health
Table 8: Respondents' agreement (Likert scale of 1 = strongly agree to 5 = strongly disagree) with statements on PDAs.* (N = 26)
Quality of PDAs Mean SD
Provide information at one's "fingertips" 2.00 0.75
A faster means to access information as compared to a text reference (e.g. CPS) 2.23 0.82
A faster means to access information as compared to a desktop or laptop computer 2.35 0.98
Help to organize information 2.46 0.90
Help to inform decisions in my patient care activities 2.50 0.99
An impetus to look up drug or disease information 2.65 1.20
Improve my patient's health outcomes 2.92 1.20
Decrease paperwork 3.35 1.16
* No significant differences were found between current personal digital assistant (PDA) and computer survey respondents' opinions (Fisher's 
Exact) regarding the PDA statements.BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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care provider role and this is supported by written feed-
back from our sample regarding frequently consulted
health professionals. Nursing colleagues are also likely to
be rated highly by NPs due to their affiliation with peers
from the same profession.
Some investigators have shown that non-human refer-
ences (e.g. textbook) are sought for more technical aspects
of prescribing (e.g. dose), whereas guidance regarding
selection of agents (i.e. right drug for an indication) is
sought from human resources (e.g. pharmacists or physi-
cians) [62]. We were unable to determine what kinds of
resources were used for specific purposes from our study.
Online and electronic resources, computers, and personal 
digital assistants
From our study, computer survey respondents ranked
online/electronic resources third in preference following
print and health professionals. Various barriers and facili-
tators to accessing information online/electronically or
via the Internet have been described in the literature
[55,63-66]. Variables that have been described by others
as barriers such as accessibility, high speed internet access,
patient volume, age, practitioner type, and technology
support did not appear to influence computer searching
for information on drugs or therapeutics related to patient
care in our results. Some qualitative feedback does how-
ever support this notion. As an example, in response to a
request for a rationale for not using computers one physi-
cian commented: "Retro tech [sic]/old fashion. I still like
to use my mind and have always been a fan of pen and
paper". Barriers that were identified with our sample
regarding the use of handheld technologies such as PDAs
included cost, time, and issues related to technology liter-
acy. Several people questioned the value of PDAs. One GP
stated when referring to a PDA: "So far I have not discov-
ered a use for one". Other respondents reinforced their
preferences for other resources (e.g. books) and resistance
to technology. When responding to barriers for the use of
PDAs, one NP commented, "My huge dislike for machin-
ery that frequently requires updating and patience". A
physician responded, "as stated, I like to use my own
mind, and can get all the info I need from books relatively
quickly". Facilitators to the use of PDAs mainly included
convenience factors such as having resources all in one
place, faster means to get information, and portability.
Our sample was not in agreement with some convenience
factors in that they did not feel that PDAs would decrease
paperwork. Practitioners from our sample felt relatively
neutral about PDAs improving patient's health outcomes
with 41% responding in this manner. Results from a sam-
ple of primary care practitioners in the US revealed that
76% agreed that the use of handheld devices for electronic
prescribing would substantially reduce medical errors and
improve the quality of health care [67].
Our study also suggests that resources such as the
Cochrane Library and its Database of Systematic Reviews
were not frequently used. This finding is similar to that of
other investigators [30,35,64]. Despite the desire of some
clinicians to use these resources, lack of confidence and
ability to use them appropriately has been found
[30,64,68,69]. Our study suggests that although this
resource is perceived as credible, current/timely, and use-
ful, it is also perceived to be somewhat inaccessible. The
Cochrane Library is available to the health professionals
(e.g. nurses, physicians, pharmacists, occupational thera-
pists, physiotherapists, etc.) in our sample through profes-
sional bodies via the Atlantic Health Knowledge
Partnership [70].
Technology training: preferences and incentives
With regard to receiving training for a new technology,
our study demonstrates that in person conferences or one
on one training sessions are the preferred means to receive
continuing education. Person to person interaction has
been reported as the preferred and most frequently used
means to access continuing education or training by other
investigators [55,71].
Our study also indicates that this group of practitioners
may benefit from accessing resources [72-80] that provide
guidance on useful drug information resources available
for devices such as PDAs. This is exemplified by one
respondent's statement "knowledge regarding good soft-
ware programs" as a barrier to the use of PDAs.
Pharmaceutical industry
The influence of the pharmaceutical industry on physician
prescribing and research outcomes has been documented
[81,82]. Although NP use of industry representatives as a
source of pharmacological information has been docu-
mented, the influence on prescribing is largely uninvesti-
gated [32,61,83-85]. The CNA competency framework
includes a statement regarding prescribing and industry
relations [23]. In our study, the physician and NP rank-
ings of industry representatives were similar. Within the
health professionals and other category, pharmaceutical
representatives were used as a resource by more of the
sample than regional drug information services and com-
parably to academic detailing services. Academic detailing
is a form of continuing  medical education where a
trained health professional visits prescribers for  a fifteen
to twenty minute session to provide objective information
regarding a therapeutic topic based on best available evi-
dence [86,87]. Following academic detailing, physician
and NP rankings of pharmaceutical industry representa-
tives were second or third for frequency of use, usefulness,
accessibility, credibility, and current/timeliness.BMC Nursing 2006, 5:5 http://www.biomedcentral.com/1472-6955/5/5
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Limitations
We do not have demographics or information regarding
the reasons why survey recipients did not respond. As per
ethical requirements to maintain confidentiality of
respondents, we were not able to match respondents from
their respective place of practice and therefore cannot con-
clude whether the practitioners within a practice setting
influenced the others' responses. The sample size of the
survey is small although it includes 88% response from
community based NPs in Nova Scotia. The generalizabil-
ity of the results is limited due to the variations in NP
scopes of practice nationally and internationally. It is
unknown whether the findings are generalizable to non-
responding physicians within Nova Scotia collaborating
with NPs or to physicians not in collaborative practices
with NPs as they were not included as a part of the sample.
Due to multiple statistical comparisons (Mann Whitney
U), the results comparing NP and physician ratings of
results should be interpreted with caution.
Conclusion
Respondent ratings of resources and preferences for
resource use were consistent with self-reported means of
conducting searches for specific drug information queries.
The use of computers and PDAs remains limited and also
matches preferences and resource ratings. Education to
this group of practitioners regarding available drug infor-
mation resources may facilitate use of computer and PDA
resources. Further research is needed to determine meth-
ods to increase the use of computers and PDAs and if use
of these technologies affects prescribing and patient out-
comes.
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